Overexpression of cyclin B1 in gastric cancer and its clinicopathological significance: An immunohistological study

Journal of Cancer Research and Clinical Oncology

Volumn 128, Issue 8, 2002, Pages 412-416

  Yasuda, Mitsuhiro ^a   Takesue, Fumio ^a   Inutsuka, Sadaaki ^a   Honda, Masayuki ^a   Nozoe, Tadahiro ^a   Korenaga, Daisuke ^a  

^a FUKUOKA DENTAL COLLEGE   (Japan)

Author keywords

Cyclin B1; Gastric cancer; Multivariate analysis; Prognosis

Indexed keywords

CYCLIN B1;

ADENOCARCINOMA; ARTICLE; CANCER CELL; CANCER INVASION; CANCER STAGING; CELL CYCLE; CELL POPULATION; CONTROLLED STUDY; CYTOPLASM; GENE OVEREXPRESSION; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOLOGY; LOGISTIC REGRESSION ANALYSIS; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH CANCER;

ADENOCARCINOMA; AGED; CYCLIN B; FEMALE; G2 PHASE; HUMANS; IMMUNOENZYME TECHNIQUES; LIVER NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; STOMACH NEOPLASMS; SURVIVAL RATE;

EID: 0036037705     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-002-0359-9     Document Type: Article

References (29)

1. Prognostic factors in gastric cancer
2. Cyclins as markers of tumor proliferation: Immunocytochemical studies in breast cancer
3. Anaphase is initiated by proteolysis rather than by the inactivation of maturation-promoting factor
4. Increased incidence of undifferentiated type of gastric cancer with tumor progression in 912 patients with early gastric cancer and 1245 with advanced gastric cancer
5. p53 regulates a G2 checkpoint through cyclin B1
6. Cyclin D1 and retinoblastoma gene expression in human breast carcinoma: Correlation with tumor proliferation and oestrogen receptor status
7. Nuclear localization of cyclin B1 controls mitotic entry after DNA damage
8. Expression of the G2-M checkpoint regulators cyclin B1 and cdc2 in nonmalignant and malignant human breast lesions. Immunocytochemical and quantitative image analyses
9. The relationship between a cyclin B1 overexpression and lymph node metastasis in human colorectal cancer
10. Aberrant expression of cyclin A and cyclin B1 proteins in oral carcinoma
11. Nuclear localization of cyclin B1 mediates its biological activity and is regulated by phosphorylation
12. Expression of cell cycle-regulated proteins in prostate cancer
13. Prognostic significance of cyclin expression in human osteosarcoma
14. Clinical features of the differentiated and undifferentiated types of advanced gastric carcinoma: Univariate and multivariate analyses
15. Determination of the prognostic significance of cyclin B1 overexpression in patients with esophageal squamous cell carcinoma
16. Amplification and overexpression of the cyclin D1 gene in aggressive human hepatocellular carcinoma
17. Constitutive activation of cyclin B1-associated cdc2 kinase overrides p53-mediated G2-M arrest
18. Altered expression and activity of G1/S cyclins and cyclin-dependent kinases characterize squamous cell carcinomas of the head and neck
19. Human cyclin A is adenovirus E1A-associated protein p60 and behaves differently from cyclin B
20. Cell cycle-related gene abnormalities and product expression in esophageal carcinoma
21. Prognostic value of cyclin E and p53 expression in gastric carcinoma
22. Cancer cell cycles
23. Overexpression of cyclin B1 in early-stage non-small cell lung cancer and its clinical implication
24. Regulation of the G2/M transition by p53
25. Nuclear export of cyclin B1 and its possible role in the DNA damage-induced G2-checkpoint
26. Clinical implication of cyclins, cyclin-dependent kinases, Rb and E2F1 in squamous-cell lung carcinoma
27. Overexpression of cyclin B1 in human colorectal cancers
28. Expression of cyclin E in colorectal adenomas and adenocarcinomas: Correlation with expression of Ki-67 and p53 protein